COFEPRIS regulation and the Mexican context In Mexico, the Comisin Federal para la Proteccin contra Riesgos Sanitarios (COFEPRIS) regulates pharmaceutical substances and the clinical settings in which they are administered
Mild Side Effects These side effects are reported anecdotally and tend to resolve on their own within a few days of use or dose adjustment: Headache or light-headedness Mild nausea or upset stomach (especially with oral use) Fatigue or lethargy in the first few days of use Appetite changes (increase or decrease) Injection site irritation redness, swelling, or tenderness Mild dizziness, nausea, and local irritation are among the most commonly reported side effects of subcutaneous BPC-157 injection, typically resolving within 2472 hours. Milekic, T
In an essay of neurotrophic activity, Dihexa was found to be seven orders of magnitude more potent than BDNF
Early preclinical studies have also explored its potential to support overall gastrointestinal health, though human evidence remains limited
It heals injuries and prevents some age-related diseases like cancer, heart disease and dementia. 3
